Company: GGT-PG
Filing Date: 2025-10-14
Form Type: 424B2
Source: 0001829126-25-008100
Chunk: 6

Company: GABELLI MULTIMEDIA TRUST INC.
Filing Date: 2025-10-14
Form: 424B2
Chunk 6
---
| * | The example should not be considered a representation of future expenses. The example is based on total Annual Expenses and Dividends on Preferred Shares shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at net asset value. Actual expenses may be greater or less than those assumed. Moreover, the Fund’s actual rate of return may be greater or less than the hypothetical 5% return shown in the example. |

The example includes Dividends on Preferred Shares. If Dividends on Preferred Shares were not included in the example calculation, the estimated expenses for the 1-, 3-, 5- and 10-year periods in the table above would be as follows (based on the same assumptions as above): $ 18, $ 56, $ 97, and $ 211, respectively.

<div align='center'>S-3

USE OF PROCEEDS</div>

Sales of shares of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market” as defined in Rule 415 under the 1933 Act, including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. There is no guaranty that there will be any sales of shares of our common stock pursuant to this prospectus supplement and the accompanying prospectus. Actual sales, if any, of our common stock under this prospectus supplement and the accompanying prospectus may be less than as set forth in this paragraph. In addition, the price per share of any such sale may be greater or less than the price set forth in this paragraph, depending on the market price of our common stock at the time of any such sale. As a result, the actual net proceeds we receive may be more or less than the amount of net proceeds estimated in this prospectus supplement. Assuming the sale of all 5,855,899 shares of our common stock offered and available for sale under this prospectus supplement and the accompanying prospectus at $4.19 per share (the last reported sales price per share of our common stock on October 9, 2025), we estimate that the net proceeds of this offering will be approximately $24,580,722 after deducting the estimated underwriting discount.

The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund’s investment objectives and